Catalyzing drug discovery for women's health in endometriosis and fibroids
Opal Therapeutics is a women's health biotech company building high-fidelity, patient-derived uterine organoid models of endometriosis and fibroids. Their platform helps biotech and pharma companies accelerate drug discovery and de-risk development through compound screening and biomarker validation using human preclinical data.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2024
Create a free account to see which investors have funded this company.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
